Table I.
HGB and MCH levels in relation to the clinicopathalogical variables in 399 patients with HCC.
| HGB | MCH | ||||||
|---|---|---|---|---|---|---|---|
| Variable | No. cases | ≤110 g/l n (%) (n=51) | >110 g/l n (%) (n=348) | P-value | ≤27 pg n (%) (n=88) | >27 pg n (%) (n=311) | P-value |
| Age, years | |||||||
| ≤48 | 207 | 30 (14.5) | 177 (85.5) | 0.288 | 48 (23.2) | 159 (76.8) | 0.571 |
| >48 | 192 | 21 (10.9) | 171 (89.1) | 40 (20.8) | 152 (79.2) | ||
| Gender | |||||||
| Female | 43 | 10 (23.3) | 33 (76.7) | 0.029 | 16 (37.2) | 27 (62.8) | 0.011 |
| Male | 356 | 41 (11.5) | 315 (88.5) | 72 (20.2) | 284 (79.8) | ||
| HBsAg | |||||||
| Negative | 80 | 13 (16.3) | 67 (83.7) | 0.299 | 24 (30.0) | 56 (70.0) | 0.055 |
| Positive | 319 | 38 (11.4) | 281 (88.6) | 64 (20.1) | 255 (79.9) | ||
| Cirrhosis | |||||||
| No | 86 | 10 (11.6) | 76 (88.4) | 0.717 | 23 (26.7) | 63 (73.3) | 0.236 |
| Yes | 313 | 41 (13.1) | 272 (86.9) | 65 (20.8) | 248 (79.2) | ||
| Tumor size | |||||||
| <10 | 272 | 34 (12.5) | 238 (87.5) | 0.805 | 61 (22.4) | 211 (77.6) | 0.793 |
| ≥10 | 127 | 17 (13.4) | 110 (86.6) | 27 (21.3) | 100 (78.7) | ||
| Tumor encapsulation | |||||||
| Complete | 193 | 22 (11.4) | 171 (88.6) | 0.423 | 33 (17.1) | 160 (82.9) | 0.021 |
| None | 206 | 29 (14.1) | 177 (85.9) | 55 (26.7) | 151(73.3) | ||
| Tumor number | |||||||
| Solitary | 259 | 34 (13.1) | 225 (86.9) | 0.779 | 57 (22.0) | 202 (78.0) | 0.975 |
| Multiple | 140 | 17 (12.1) | 123 (87.9) | 31 (22.1) | 109 (77.9) | ||
| Vascular invasion | |||||||
| Absent | 326 | 42 (12.9) | 284 (87.1) | 0.898 | 75 (23.0) | 251 (77.0) | 0.333 |
| Present | 73 | 9 (12.3) | 64 (87.7) | 13 (17.8) | 60 (82.2) | ||
| Differentiation | |||||||
| I–II | 285 | 34 (11.9) | 251 (88.1) | 0.420 | 65 (22.8) | 220 (77.2) | 0.567 |
| III–IV | 114 | 17 (14.9) | 97 (85.1) | 23 (20.2) | 91 (79.8) | ||
| TNM stage | |||||||
| I | 225 | 32 (14.2) | 193 (85.8) | 0.327 | 49 (21.8) | 176 (78.2) | 0.879 |
| II–III | 174 | 19 (10.9) | 155 (89.1) | 39 (22.4) | 135 (77.6) | ||
| AFP, µg/l | |||||||
| ≤25 | 127 | 21 (16.5) | 106 (83.5) | 0.125 | 30 (23.6) | 97 (76.4) | 0.606 |
| >25 | 272 | 30 (11.0) | 242 (89.0) | 58 (21.3) | 214 (78.7) | ||
HGB, hemoglobin; MCH, mean corpuscular hemoglobin; HCC, hepatocellular carcinoma; HBsAg, hepatitis B surface antigen; TNM, tumor node metastasis; AFP, α-fetoprotein.